Furthermore, FOXO3A has been shown to reduce mitochondrial oxidative phosphorylation and glycolysis, thereby inhibiting tumor cell growth and survival by decreasing cellular energy production in breast cancer cells. Here, FOXO3 is linked to breast cancer.